Ataxin 7 Explained

ataxin 7
Hgncid:10560
Symbol:ATXN7
Altsymbols:SCA7
Entrezgene:6314
Omim:607640
Refseq:NM_000333
Uniprot:O15265
Chromosome:3
Arm:p
Band:21.1
Locussupplementarydata:-p12

Ataxin 7 (ATXN7) is a protein of the SCA7 gene, which contains 892 amino acids with an expandable poly(Q) region close to the N-terminus. The expandable poly(Q) motif region in the protein contributes crucially to spinocerebellar ataxia (SCA) pathogenesis by the induction of intranuclear inclusion bodies.[1] ATXN7 is associated with both olivopontocerebellar atrophy type 3 (OPCA3) and spinocerebellar ataxia type 7 (SCA7).

CAG repeat leads to pathological protein misfolding. In ataxin-7 gene has shown to cause cerebellar and brainstem degeneration as well as retinal conerod dystrophy. Polyglutamine (polyQ) expansion at the N-terminus of ataxin-7 causes protein aggregation, leading to the symptoms of ataxia with visual loss.[2]

Research suggest that silencing of ataxin-7 in the retina by RNAi can be a possible therapeutic strategy for patients with SCA7 retinal degeneration.[3]

Further reading

External links

Notes and References

  1. Scheel H, Tomiuk S, Hofmann K . Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics . Human Molecular Genetics . 12 . 21 . 2845–2852 . November 2003 . 12944423 . 10.1093/hmg/ddg297 . free .
  2. Book: The molecular and cellular basis of neurodegenerative diseases: underlying mechanisms. Wolfe MS . 18 April 2018. 978-0-12-811304-2. 1040033113. Wolfe . Michael S. . Elsevier Science .
  3. Ramachandran PS, Bhattarai S, Singh P, Boudreau RL, Thompson S, Laspada AR, Drack AV, Davidson BL . RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration . PLOS ONE . 9 . 4 . e95362 . 2014 . 24759684 . 3997397 . 10.1371/journal.pone.0095362 . free . 2014PLoSO...995362R .